skip to primary navigationskip to content
 

2016 EUROPEAN PATENT OFFICE INVENTOR AWARD

last modified May 23, 2016 12:01 PM
Helen Lee (Haematology) was selected from 470 nominations by the European Patent Office to be one of the 3 finalists for SAMBA, the technology she and her group have developed. They have greatly simplified the detection of infectious diseases by nucleic acid amplification suitable for resource-poor settings.
Helen Lee (Haematology) was selected from 470 nominations by the European Patent Office to be one of the 3 finalists for SAMBA, the technology she and her group have developed. They have greatly simplified the detection of infectious diseases by nucleic acid amplification suitable for resource-poor settings. Below is a link to the interview the European Patent Office made with Helen, where you can see the technology in action.
 
There is a prize by popular vote and if you would like to show your support for this worthy cause, please use the following link which takes less than a minute to do. The  voting has already started and will end May 31. You can vote once per day everyday until the deadline: 
 

The new Capella building- CITIID

See the home of CITIID being built in this fantastic time-lapse video. From basement to water tight in 17 months. The Capella building will be finished in 2019.

Fibroblast

‘Fibroblast’ has been developed from a conversation between Harold Offeh and Dr Alice Denton, a scientist based at the Babraham Institute and a member of the Cambridge Immunology Network. Offeh was particularly interested in the character and roles played by particular cells in the immune system, as well as the immune system’s role as a primary source of protection and care. The film takes as a starting point microscopic images of broblast cells, an area of research for Dr Denton.

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more